Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial


15959

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial

Neurology

Johnston Karen, C

UVA Health System, Department of Neurology is engaged in a research study to determine the best treatment for blood glucose control in hyperglycemic acute ischemic stroke patients. The purpose of this study is to determine if treating high blood sugar in ischemic stroke patients with IV insulin shows better recoveries than the current standard insulin protocol for high blood sugar. The study involves medical and neurological exams that are standard of care for stroke patients, including 8-20 blood glucose checks per day, and insulin for all patients. The treatment period lasts up to 72 hours, or until the participant is discharged from the hospital. The study team will conduct a phone interview with the participant about 6 weeks after the stroke, and will also complete assessments during the participant’s regularly scheduled clinic stroke follow up visit about 3 months after the stroke. No compensation is provided for this study. Contact Information: Study Coordinator | Valerie Odell (email: vao3xf@virginia.edu) Project Manager | Amy Fansler (email: acf7h@virginia.edu) IRB-HSR 15959 Title: Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial: An NIH-NINDS funded, multicenter, prospective, randomized, controlled clinical trial Principal Investigator: Karen Johnston, MD MSc


Adult

Stroke

Neurology

Ill

No Compensation

Amy Fansler

acf7h@virginia.edu

4349826027